Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female older than 17 years.~2. Clinical diagnosis of probable multiple system atrophy~3. Provide written informed consent to participate in the study~4. Understand that they may withdraw their consent at any time~Exclusion Criteria:~1. Women who are pregnant or lactating~2. In the investigator's opinion, have any other significant systemic, hepatic, cardiac or renal illness.~3. In the investigator's opinion, the subjects are significantly dehydrated, as determined by clinical evaluation including measurement of skin turgor, blood urea nitrogen and creatinine values.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Interventions included monthly infusions of intravenous immunoglobulin.

Based on this trial design, predict the completion outcome and termination type (if applicable).